ClinicalTrials.gg
RecruitingNCT06385977Updated Jul 3, 2024

Risk Factors for Chronic Prostatitis Patients in Northwest China

An observational study in Chronic Prostatitis With Chronic Pelvic Pain Syndrome, sponsored by Shaanxi Provincial People's Hospital. Recruiting at 1 site in China. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by Shaanxi Provincial People's Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2016; still recruiting 10 years 10 months later.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
400
Ages
18 Years and older
Sex
Male
01

Study summary

The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are:

  • Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome
  • Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome.

Participants will:

  • Independently receive a survey questionnaire on lifestyle, medication, and sexual habits.
  • Symptomatic individuals will undergo additional prostate fluid examination for diagnosis.

Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.

Read the detailed description

All participants were asked to fill out a questionnaire which was modified based on Zhang Ran's research. The questionnaire contained the following parts: patient's general situation, dietary habits, disease status, medication, lifestyle, sexual habits and NIH-CPSI index (National Institutes of Health Chronic Prostatitis Symptom Index). Furthermore, the patients underwent digital rectal examination, expressed prostatic secretion microscopy and microbial culture, urinalysis, urine microbial culture and transrectal ultrasonography.

02

Conditions studied

  • Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Browse trials for

03

In context

Prostatitis

88 studies on the registry are indexed under Prostatitis; 11 are open to participants now.

This study's planned enrollment of 400 is above the median of 147 across 13 observational studies indexed under Prostatitis.

Browse Prostatitis studies →

Lead sponsor

Shaanxi Provincial People's Hospital is the lead sponsor of 9 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

All patients are from Urology Clinic, while all the controls are recruited from the physical examination center of our hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Discomfort or pain in the pelvic region or perineum;
  • Symptoms lasting for at least 3 months;
  • NIH-CPSI pain score of ≥ 4;
  • Controls are volunteers who do not present any prostatitis-related symptoms.

Exclusion criteria

Exclusion Criteria:

  • Prostate cancer;
  • Benign prostatic hyperplasia with a post-void residual urine volume of >50 ml;
  • Acute urinary tract infection.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • case group

    participates diagnosed with Chronic prostatitis/chronic pelvic pain syndrome

    Behavioral: lifestyle · Behavioral: sexual habits · Drug: medication

  • control group

    participates without Chronic prostatitis/chronic pelvic pain syndrome

    Behavioral: lifestyle · Behavioral: sexual habits · Drug: medication

Interventions

  • Behaviorallifestyle

    Life habits and personal preferences

  • Behavioralsexual habits

    Sexual experience and activities

  • use of medication

06

What researchers measure

Primary outcomes

  1. Odds Ratio

    The ratio of exposed to unexposed individuals in the case group divided by the ratio of exposed to unexposed individuals in the control group

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06385977
Lead sponsor
Shaanxi Provincial People's Hospital
Responsible party
Sponsor
First posted
Apr 26, 2024
Start date
Jan 2016
Primary completion
Jun 30, 2024 (estimated)
Completion
Jul 1, 2024 (estimated)
Last update
Jul 3, 2024

Study contacts

Qian Deng, Doctor
Contact
dengqian@xiyi.edu.cn
86-029-85251331 ext. 2079
Chun Du, Professor
study director · Shaanxi Provincial People's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion